Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy: a Randomised, Comparative, Open-label Trial
Phase of Trial: Phase IV
Latest Information Update: 27 Dec 2018
At a glance
- Drugs Iron isomaltoside 1000 (Primary) ; Ferrous fumarate
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- Sponsors Pharmacosmos
- 17 Dec 2018 Planned End Date changed from 30 Dec 2018 to 30 Jun 2020.
- 17 Dec 2018 Planned primary completion date changed from 30 Aug 2018 to 30 Dec 2019.
- 14 Mar 2018 Status changed from not yet recruiting to recruiting.